Open AccessEvaluation of mupA EVIGENE Assay for Determination of High-Level Mupirocin Resistance in Staphylococcus aureus
Author(s) -
Anne Rasmussen,
Robert Skov,
Richard A. Venezia,
J. Kristie Johnson,
Henrik Stender
Publication year - 2010
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.00088-10
Subject(s) - mupirocin , staphylococcus aureus , microbiology and biotechnology , micrococcaceae , medicine , methicillin resistant staphylococcus aureus , antibacterial agent , biology , antibiotics , bacteria , genetics
Mupirocin is widely used to decolonize patients carryingStaphylococcus aureus , especially methicillin-resistantS. aureus (MRSA). The aim of this study was to determine the presence of high-level mupirocin resistance by a new commercially availablemupA genotypic diagnostic product,mupA EVIGENE assay (AdvanDx).